Transcutaneous Neuromodulation improved inflammation and sympathovagal ratio in patients with primary biliary ssscholangitis and inadequate response to Ursodeoxycholic acid: a pilot study

• প্রধান লেখক: Hui Yang (লেখক), Hang Yang (লেখক), Lixia Wang (লেখক), Honggang Shi (লেখক), Bojia Liu (লেখক), Xue Lin (লেখক), Qingyong Chang (লেখক), Jiande D. Z. Chen (লেখক), Zhijun Duan (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: BMC, 2020-08-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Abstract Background At present, ursodeoxycholic acid (UDCA) is internationally recognized as a therapeutic drug in clinic. However, about 40% Primary Biliary Cholangitis (PBC) patients are poor responders to UDCA. It has been demonstrated that Transcutaneous Neuromodulation (TN) can be involved in g...